See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

CI&T (NYSE: CINT, "Company"), a global technology transformation specialist and fast-growing public company, today announces ...

We also have top-rated plays from the SportsLine Projection Model for college basketball, the NBA, NHL, NFL and college ...

After two years of cooling down from the post-pandemic boom, fundamentals stabilized in the third quarter of 2025, and few ...

REITs offer strong income, value, and growth potential amid today's market shifts. Click here to read the full analysis.

Q3 2025 Earnings Call Transcript November 6, 2025 Globus Medical, Inc. beats earnings expectations. Reported EPS is $1.18, ...

Ian Anderson from Merchant West Investments notes: ‘A lot of it is driven by declining interest rates and lower borrowing ...

Week 11 buy low, sell high candidates for 2025. Jorden's trade analyzer article looking at overvalued and undervalued players ...

Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and ...

Third Quarter Highlights Per Class B share(3): $1.21 adjusted basic earnings up 11.0%; $1.21 basic earnings up 12.0% Sales increased 6.3% on 3.7% organic growth, 0.1% acquisition growth and 2.5% ...

Helping students to develop math fluency takes more than just flash cards. It requires teaching them how to think about ...

Stage 5: Justify thinking. A vital habit that many students need to solidify is recontextualizing after they solve ...